XML 23 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note C - Marketable Equity Securities
3 Months Ended
Mar. 31, 2017
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
NOTE C: MARKETABLE EQUITY SECURITIES
The Company accounts for its marketable securities in accordance with ASC Topic
320,
(“ASC Topic
320”),
Investments-Debt and Equity Securities
. ASC Topic
320
requires companies to classify their investments as trading, available-for-sale, or held-to-maturity. The Company’s investments in marketable securities are classified as available-for-sale and consist of equity securities. Management determines the appropriate classification of these securities at the time of purchase and re-evaluates such designation as of each balance sheet date. The cost of securities sold is based on the specific identification method, and interest and dividends on securities are included in non-operating income (loss).
 
Marketable equity securities are carried at fair value, with the unrealized gains and losses, net of tax, included as a component of accumulated other comprehensive income in shareholders’ equity. Realized gains and losses and declines in value judged to be other-than-temporary on available-for-sale securities, if any, are included in the determination of net income. A quarterly evaluation is performed in order to judge whether declines in value below cost should be considered temporary and when losses are deemed to be other-than-temporary. Several factors are considered in this evaluation process including the severity and duration of the decline in value, the financial condition and near-term outlook for the specific issuer and the Company’s ability to hold the securities.
 
Based upon this evaluation, the Company determined that an impairment charge was
not
necessary for the quarter ended
March
31,
2017.
For the quarter ended
March
31,
2016,
the evaluation resulted in an impairment charge of approximately
$235,000
in the Company’s non-operating income (loss) in its consolidated statements of operations.
 
The following table sets forth cost, market value and unrealized gains on equity securities as of
March
31,
2017
and
December
31,
2016.
 
   
March 31, 2017
   
December 31, 2016
 
   
(in thousands)
 
Fair market value
  $
25,520
    $
27,621
 
Cost
   
14,955
     
15,569
 
Net unrealized gains
  $
10,565
    $
12,052
 
 
The following table sets forth the gross unrealized gains and losses on the Company’s marketable securities as of
March
31,
2017
and
December
31,
2016.
 
   
March 31, 2017
   
December 31, 2016
 
   
(in thousands)
 
Gross unrealized gains
  $
10,686
    $
12,161
 
Gross unrealized losses
   
121
     
109
 
Net unrealized gains
  $
10,565
    $
12,052
 
 
As of
March
31,
2017
and
December
31,
2016,
the total net unrealized gain, net of deferred income taxes, in accumulated other comprehensive income was approximately
$6,554,000
and
$7,476,000,
respectively.
 
For the quarter ended
March
31,
2017,
the Company had net unrealized gains in market value on its marketable equity securities of approximately
$922,000,
net of deferred income taxes. For the year ended
December
31,
2016,
the Company had net unrealized gains in market value on its marketable equity securities of approximately
$2,166,000,
net of deferred income taxes.
 
For the quarter ended
March
31,
2017,
the Company recognized dividends of approximately
$221,000
in non-operating income (loss) in its statements of operations. For the quarter ended
March
31,
2016,
the Company recognized dividends of approximately
$259,000
in non-operating income (loss) in its consolidated statements of operations.
 
There were
no
reclassifications of marketable securities between trading and available-for- sale categories during the
first
three
months of
2017
or
2016.
 
The following table shows the Company’s net realized gains and (losses) during the
first
three
months of
2017
and
2016
on certain marketable equity securities. The cost of securities sold is based on the specific identification method, and interest and dividends on securities are included in non-operating income (loss).
 
   
Three Months Ended
 
   
March 31, 2017
   
March 31, 2016
 
   
(in thousands)
 
Realized gain (loss)
               
Sale proceeds
  $
2,367
    $
279
 
Cost of securities sold
   
585
     
368
 
Realized gain (loss)
  $
1,782
    $
(89
)
                 
Realized gain (loss), net of taxes
  $
1,089
    $
(55
)
 
At
March
31,
2017,
the Company’s investments’ approximate fair value of securities in a loss position and related gross unrealized losses were
$2,127,000
and
$121,000,
respectively. At
December
31,
2016,
the Company’s investments’ approximate fair value of securities in a loss position and related gross unrealized losses were
$1,340,000
and
$109,000,
respectively. As of
March
31,
2017
and
December
31,
2016,
there were
no
investments that had been in a continuous unrealized loss position for
twelve
months or longer.
 
The market value of the Company’s equity securities are periodically used as collateral against any outstanding margin account borrowings. As of
March
31,
2017
and
December
31,
2016,
the Company had outstanding borrowings of approximately
$7,768,000
and
$10,358,000,
respectively, under its margin account. Margin account borrowings are used for the purchase of marketable equity securities and as a source of short-term liquidity and are included in Accrued expenses and other liabilities on our consolidated balance sheets.